Bellecapital International Ltd. Halozyme Therapeutics, Inc. Transaction History

Bellecapital International Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 13, 2021	SELL	$39.51 - $51.45 $391,781 - $510,178	-9,916 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$25.81 - $43.62 $46,045 - $77,818	-1,784 Reduced 15.25%	9,916 $424,000
Q1 2020 Apr 24, 2020	BUY	$13.9 - $21.83 $162,630 - $255,410	11,700 New	11,700 $210,000

539

126M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.77B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.